A selective novel low‐molecular‐weight inhibitor of I κ B kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Pulmonary inflammatory diseases such as asthma are characterized by chronic, cell‐mediated inflammation of the bronchial mucosa. Recruitment and activation of inflammatory cells is orchestrated by a variety of mediators such as cytokines, chemokines, or adhesion molecules, the expression of which is regulated via the transcription factor nuclear factor kappa B (NF‐κ B). NF‐κ B signaling is controlled by the inhibitor of kappa B kinase complex (IKK), a critical catalytic subunit of which is IKK‐β. We identified COMPOUND A as a small‐molecule, ATP‐competitive inhibitor selectively targeting IKK‐β kinase activity with a Ki value of 2 n M. COMPOUND A inhibited stress‐induced NF‐κ B transactivation, chemokine‐, cytokine‐, and adhesion molecule expression, and T‐ and B‐cell proliferation. COMPOUND A is orally bioavailable and inhibited the release of LPS‐induced TNF‐α in rodents. In mice COMPOUND A inhibited cockroach allergen‐induced airway inflammation and hyperreactivity and efficiently abrogated leukocyte trafficking induced by carrageenan in mice or by ovalbumin in a rat model of airway inflammation. COMPOUND A was well tolerated by rodents over 3 weeks without affecting weight gain. Furthermore, in mice COMPOUND A suppressed edema formation in response to arachidonic acid, phorbol ester, or edema induced by delayed‐type hypersensitivity. These data suggest that IKK‐β inhibitors offer an effective therapeutic approach for inhibiting chronic pulmonary inflammation. British Journal of Pharmacology (2005) 145, 178–192. doi:10.1038/sj.bjp.0706176
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129 · cited 1×
“Humans dendritic cells (DCs) were generated from PBMC as described with minor modifications (Sallusto & Lanzavecchia, 1994).”
MethodMissing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · cited 3×
“GCs inhibit airway inflammation by directly interact- ing with and inhibiting the activity of the transcription factors NF-kB and AP-1 (De Bosscher et al., 2003; Leung & Bloom, 2003).”
BackgroundDas, J., Chen, C.-H., Yang, L., Cohn, L., Ray, P., & Ray, A. (2001) · Nature Immunology · doi:10.1038/83158 · Cited by 518 · cited 2×
“CD4-positive T cells from p50 / mice failed to induce Gata3 expression, a transcription factor present in Th2 but not Th1 cells, and plays a critical role in Th2 differentiation and allergic airway inflammation in vivo (Das et al., 2001).”
BackgroundSevere liver degeneration and lack of NF-κ B activation in NEMO/IKKγ-deficient mice
Rudolph, D., Yeh, W.-C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., & Mak, T. W. (2000) · Genes & Development · doi:10.1101/gad.14.7.854 · Cited by 479
IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis
Sil, A. K., Maeda, S., Sano, Y., Roop, D. R., & Karin, M. (2004) · Nature · doi:10.1038/nature02421 · Cited by 211
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid
Camandola, S., Leonarduzzi, G., Musso, T., Varesio, L., Carini, R., Scavazza, A., Chiarpotto, E., Baeuerle, P. A., & Poli, G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1857 · Cited by 188
Cited by
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
NF-κB Signaling: Multiple Angles to Target OA
B. Marcu, K., Otero, M., Olivotto, E., Maria Borzi, R., & B. Goldring, M. (2010) · Current Drug Targets · doi:10.2174/138945010791011938 · Cited by 565
NF-kappaB Signaling in Chronic Inflammatory Airway Disease
Schuliga, M. (2015) · Biomolecules · doi:10.3390/biom5031266 · Cited by 428
NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
Wang, S., Liu, Z., Wang, L., & Zhang, X. (2009) · Cellular & Molecular Immunology · doi:10.1038/cmi.2009.43 · Cited by 405
Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease
Edwards, M. R., Bartlett, N. W., Clarke, D., Birrell, M., Belvisi, M., & Johnston, S. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.003 · Cited by 375
“IKK-β inhibition has been effective in LPS models of COPD (Ziegelbauer et al., 2005; Birrell et al., 2006).”
BackgroundMethodInfluential
Metadata
- Authors
- Ziegelbauer, K., Gantner, F., Lukacs, N. W., Berlin, A., Fuchikami, K., Niki, T., Sakai, K., Inbe, H., Takeshita, K., Ishimori, M., Komura, H., Murata, T., Lowinger, T., & Bacon, K. B.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 145
- Issue
- 2
- Pages
- 178-192
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1968730445
- Cited by
- 146
- References
- 7
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A selective novel low‐molecular‐weight inhibitor of I κ B kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity. https://app.cochat.ai/papers/10.1038/sj.bjp.0706176
- The paper
- Ziegelbauer, K., Gantner, F., Lukacs, N. W., Berlin, A., Fuchikami, K., Niki, T., Sakai, K., Inbe, H., Takeshita, K., Ishimori, M., Komura, H., Murata, T., Lowinger, T., & Bacon, K. B. (2005). A selective novel low‐molecular‐weight inhibitor of I κ B kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706176
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.